Hybrid Nanocarriers for Cancer Therapy: Advancements in Co-Delivery of Gene Therapy and Immunotherapy
Kulzhan Berikkhanova, Isah Inuwa, Abdulrahman Garba Jibo, Nurzhan Berikkhanov, Nurzhan Bikhanov, Yessenkhan Sultan, Ardak Omarbekov · 2025
Read Hybrid Nanocarriers for Cancer Therapy: Advancements in Co-Delivery of Gene Therapy and Immunotherapy by Kulzhan Berikkhanova, Isah Inuwa, Abdulrahman Garba Jibo, Nurzhan Berikkhanov, Nurzhan Bikhanov, Yessenkhan Sultan, Ardak Omarbekov (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12785744.txt.
Description
Kulzhan Berikkhanova and co-authors reviewed in 2025 hybrid nano carriers that ship gene therapy and immune therapy in one load for cancer. Each of those two cures works, yet each is blocked in the clinic by poor delivery, fast decay, and quick clear-out by the body. A hybrid carrier blends two or more shells or cores to guard the load and aim it at the tumor.
The review sets hybrid builds side by side on load fit, body path, immune sway, and how near they are to clinic use. Tumor traits that bend their work get a hard look. Smart shells that react to cues, coats that ape body cells, and AI-aided design are named as the next wave. Gaps in proof and in making are flagged.
Catalog record
| CREATOR | Kulzhan Berikkhanova, Isah Inuwa, Abdulrahman Garba Jibo, Nurzhan Berikkhanov, Nurzhan Bikhanov, Yessenkhan Sultan, Ardak Omarbekov |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 87 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |